Journal of Vascular and Interventional Radiology最新文献

{"title":"Embolotherapy for pulmonary arteriovenous malformations in the pediatric population with hereditary hemorrhagic telangiectasias - a retrospective case series.","authors":"Haseeb Mukhtar, Vivek Iyer, Nadir Demirel, Emily C Bendel, Haraldur Bjarnason, Sanjay Misra","doi":"10.1016/j.jvir.2025.01.047","DOIUrl":"https://doi.org/10.1016/j.jvir.2025.01.047","url":null,"abstract":"<p><strong>Purpose: </strong>To document the outcomes of embolotherapy for pulmonary arteriovenous malformation (pAVM) management, and investigate factors associated with pAVM persistence after embolotherapy in pediatric patients with hereditary hemorrhagic telangiectasia (HHT).</p><p><strong>Materials and methods: </strong>Pediatric patients with HHT who received embolotherapy for pAVMs at the institute were retrospectively identified from January 1^st, 1999, to January 31^st, 2024. Cases with adequate clinical and imaging follow-up and without prior pAVM treatment at another institute were included. Demographic, clinical, and procedural data were obtained from the electronic health record. Univariate Cox proportional hazard models were used to determine factors associated with primary pAVM persistence (re-establishment of an arteriovenous connection in a pAVM after the first embolotherapy).</p><p><strong>Results: </strong>Twenty-one patients (median age=15 years; range:3-19 years) underwent embolotherapy for 65 different pAVMs (Median follow-up time=7.56 years; range:0.13-24.4 years). In total, 3 procedural adverse events occurred. Primary persistence occurred in 23.1% of the treated pAVMs with recanalization only being the most common cause of (73.3%) followed by untreated feeders (20.0%) and recanalization along with formation of new collaterals to the pAVM (6.67%). Age less than the median cutoff of 15 years (p=0.044) and greater maximum diameter of the plugs/coils (p=0.011) were significantly associated with primary persistence on univariate analysis.</p><p><strong>Conclusion: </strong>Embolotherapy of pAVMs in pediatric patients with HHT is safe, with a high rate of persistence when predominantly coils are used. The risk of primary persistence was associated with age less than 15 years, and the use of larger diameter plugs/coils.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143124004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Percutaneous Puncture from a Pancreatic Duct Leak into the Stomach to Treat a Pancreaticocutaneous Fistula","authors":"Rhett Bouche MD,&nbsp;Mehran Fotoohi MD","doi":"10.1016/j.jvir.2024.09.012","DOIUrl":"10.1016/j.jvir.2024.09.012","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages 357-359"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142331310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"IR Physician Compensation at U.S. Medical Schools: Trends and Segments","authors":"Ajay Malhotra MD, MMM ,&nbsp;Dheeman Futela MBBS ,&nbsp;Mihir Khunte BS ,&nbsp;Xiao Wu MD ,&nbsp;Seyedmehdi Payabvash MD ,&nbsp;Dheeraj Gandhi MD ,&nbsp;Julius Chapiro MD, PhD ,&nbsp;Richard Duszak MD","doi":"10.1016/j.jvir.2024.10.016","DOIUrl":"10.1016/j.jvir.2024.10.016","url":null,"abstract":"<div><h3>Purpose</h3><div>To assess recent U.S. medical school trends in compensation for academic interventional radiology (IR) faculty and compensation characteristics based on rank, gender, and race/ethnicity.</div></div><div><h3>Methods</h3><div>Data for IR and diagnostic radiology (DR) faculty compensation were obtained from the Association of American Medical Colleges (AAMC), which annually surveys U.S. medical schools. IR faculty compensation data were analyzed from 2017 to 2023 with regard to rank, gender, and race/ethnicity and compared with DR faculty compensation.</div></div><div><h3>Results</h3><div>AAMC Faculty Salary Survey data for 2023 included responses for 874 IR faculty members, including 21 instructors, 457 assistant professors, 208 associate professors, 130 full professors, 42 chiefs, and 16 chairs. Median compensation increased by a rate of 5.0% per year for instructors and 3.0%–3.6% per year for all other ranks. Surveyed median and 25th and 75th percentile compensation for IR faculty were consistently greater than those of DR faculty at all ranks except chairs. From 2020 to 2023, this difference in compensation trended downward. Compensation for women was lower than men, with a gender pay difference of $35,000 (8.4%), $33,000 (7.5%), $26,000 (5.1%), and $32,000 (6.2%) for instructors, assistant, associate, and full professors, respectively, in 2023. In 2023, compared with White assistant professors, Asians made 94 cents, Black/African Americans made 97 cents, and Hispanic/Latinx/Spanish-origin physicians made 95 cents on the dollar, at the same rank.</div></div><div><h3>Conclusions</h3><div>IR faculty compensation has barely kept pace with inflation over recent years, overall increasing with rank, and overall higher than for DR counterparts.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages 347-354.e1"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Including the Hollow Viscera (Stomach or Bowel) within the Ice Ball during Cryoablation: A Review of Adverse Events","authors":"Artyom Abramyan DO ,&nbsp;David Schaub BS ,&nbsp;Salil Kalarn DO ,&nbsp;Zachary Fitzgerald MD ,&nbsp;Daniel Goldberg MD ,&nbsp;Jack Hannallah MD ,&nbsp;Gregory Woodhead MD, PhD ,&nbsp;Shamar Young MD","doi":"10.1016/j.jvir.2024.09.028","DOIUrl":"10.1016/j.jvir.2024.09.028","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the safety of including hollow viscus (stomach or bowel) in the ice ball during cryoablation.</div></div><div><h3>Materials and Methods</h3><div>Forty-three patients who underwent 50 cryoablations between January 1, 2012, and February 1, 2023, were retrospectively reviewed and compared with a control cohort of those who underwent cryoablation without hollow visceral involvement (n = 86). Adverse events (AEs) were stratified by the Society of Interventional Radiology (SIR) AE classification system, 2017. AEs occurring within 12 months and factors that may affect the AE rate, such as degree of hollow visceral involvement and segment of gastrointestinal tract involved, were reviewed.</div></div><div><h3>Results</h3><div>Fourteen AEs occurred in 13 patients (13/43, 30.2%). This included 7 Grade 1 (7/43, 16.3%), 3 Grade 2 (3/43, 7.0%), and 4 Grade 3 (4/43, 9.3%) AEs. Of them, 1 Grade 3 AE was judged to be related to bowel involvement (1/43, 2.3%). When comparing AEs by degree of visceral wall involvement, there were more injuries with the full-thickness visceral wall cases (6/9, 66.7%) than with partial-thickness visceral wall cases, but the findings were not statistically significant (<em>P</em> = .140). When investigating AEs by segment of the gastrointestinal tract involved, 7 (7/14, 50%), 10 (10/17, 58.8%), and 4 (4/19, 21.1%, <em>P</em> = .055) were found when the stomach, small bowel, and large bowel were involved, respectively. No significant differences in AEs (13/43, 30.2%, vs 31/86, 36%; <em>P</em> = .511) or severe AEs (4/43, 9.3%, vs 9/86, 10.5%; <em>P</em> = .836) were found between the study and control cohorts.</div></div><div><h3>Conclusions</h3><div>Findings from this single-center retrospective experience suggest that hollow visceral wall involvement by the ice ball during cryoablation resulted in a lower-than-expected rate of AEs for bowel-related injuries.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages 256-263"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and Effectiveness of Drug-Eluting Embolic Bronchial Arterial Chemoembolization for Lung Cancer: A Systematic Review and Meta-Analysis","authors":"Congsheng Tang MBBS ,&nbsp;Qifan He MM ,&nbsp;Yue Xiong MBBS ,&nbsp;Zhonghua Chen MM","doi":"10.1016/j.jvir.2024.10.023","DOIUrl":"10.1016/j.jvir.2024.10.023","url":null,"abstract":"<div><h3>Purpose</h3><div>To assess the effectiveness and safety of drug-eluting embolic (DEE) bronchial arterial chemoembolization (BACE) in lung cancer and compare its outcomes with those of conventional BACE (cBACE).</div></div><div><h3>Materials and Methods</h3><div>A comprehensive search was conducted across PubMed, Embase, Cochrane Library, Web of Science, CNKI, VIP, and Wanfang databases. Random-effects model analysis was applied when I² was ≥50%; otherwise, fixed-effects model analysis was used. Subgroup analysis was performed for I² values of ≥50%. Eighteen studies involving 681 patients were included, with 501 patients receiving DEE-BACE and 110 patients undergoing cBACE.</div></div><div><h3>Results</h3><div>Among patients with lung cancer treated with DEE-BACE, the pooled objective response rates (ORRs) at 1 and 6 months were 64.4% and 50.3%, respectively; the disease control rates (DCRs) at 1, 3, and 6 months were 93.4%, 74.4%, and 71.7%, respectively. The 1-year overall survival and progression-free survival rates were 48.2% and 22.5%, respectively. The incidences of adverse events such as cough, fever, chest discomfort, nausea, fatigue, and leukopenia were reported at 30.7%, 22.8%, 22.4%, 29.6%, 7.4%, and 21.8%, respectively. Compared with the cBACE group, the DEE-BACE group exhibited higher 1-month DCR (pooled relative risk [RR], 1.236; 95% confidence interval [CI], 1.028–1.486) and 6-month ORR (pooled RR, 2.036; 95% CI, 1.226–3.383) and DCR (pooled RR, 1.824; 95% CI, 1.249–2.662). Both DEE-BACE and cBACE exhibited similar rates of adverse events.</div></div><div><h3>Conclusions</h3><div>DEE-BACE presents a favorable effectiveness and safety profile for lung cancer treatment compared with cBACE, particularly for nonresectable cases or when chemotherapy or radiation therapy options are limited. However, the lack of direct comparisons with standard treatments requires cautious interpretation of these results.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages 221-236.e8"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142548623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Limited Effectiveness in Early Human Clinical Experience with Pulsed Electrical Field Ablation","authors":"Mohammad Reza Rouhezamin MD ,&nbsp;Florian J. Fintelmann MD ,&nbsp;Ambrose J. Huang MD ,&nbsp;Ronald Steven Arellano MD ,&nbsp;Sara Smolinski-Zhao MD ,&nbsp;Dipesh M. Patel MD ,&nbsp;Eric Paul Wehrenberg-Klee MD ,&nbsp;Raul N. Uppot MD","doi":"10.1016/j.jvir.2024.10.033","DOIUrl":"10.1016/j.jvir.2024.10.033","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate oncological outcomes, abscopal effect, and adverse events (AEs) of pulsed electrical field (PEF) ablation of tumors in the chest, abdomen, and pelvis.</div></div><div><h3>Materials and Methods</h3><div>PEF ablations performed at an academic medical center between May 2023 and January 2024 were retrospectively analyzed. Eleven patients (4 males and 7 females; age, 58 years ± 19) underwent 11 PEF sessions targeting 13 tumors (lung metastasis from solitary fibrous tumor [n = 3] and colorectal carcinoma (CA) [n = 1], osteosarcoma pleural metastases [n = 2], hepatocellular CA [n = 2], liver metastasis from colorectal CA [n = 1] and leiomyosarcoma [n = 1], metastatic melanoma to the pancreas [n = 1], metastatic retroperitoneal lymph node from endometrial CA [n = 1], and recurrence of endometrial CA in the vaginal cuff [n = 1]) with the goal of complete coverage (n = 11/13) or debulking (n = 2/13). The mean tumor diameter was 1.9 cm (SD ± 1.0; range, 0.4–3.3 cm). Cross-sectional imaging follow-up was 5.3 months (SD ± 2.2; range, 1.9–7.9 months). Oncological outcomes, abscopal effect, and AEs categorized according to the Society of Interventional Radiology (SIR) guidelines were analyzed.</div></div><div><h3>Results</h3><div>Of 11 tumors that underwent ablation for complete coverage, complete coverage was achieved for 1 (9%), and residual was detected in 9 (81%). Ten (91%) of 11 patients showed either residual, local, or distant progression within a median of 3 months. No abscopal effect was observed. There were 2 mild and 2 severe AEs.</div></div><div><h3>Conclusions</h3><div>PEF ablation showed a low rate of complete coverage (9%) and a high rate (91%) of residual, local, or distant progression. No abscopal effect was observed in any patient within a median of 5.1 months after the ablation.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages 274-281"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142631682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"When Does Chat-GPT Refer Someone to an Interventional Radiologist?","authors":"Chloe G. Cross MD ,&nbsp;Hayden L. Hofmann BS ,&nbsp;Busra Cangut MD ,&nbsp;Kirema Garcia-Reyes MD ,&nbsp;Vivian L. Bishay MD ,&nbsp;Jenanan Vairavamurthy MD","doi":"10.1016/j.jvir.2024.10.009","DOIUrl":"10.1016/j.jvir.2024.10.009","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages 355-357.e23"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142479268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Microembolization Effects of Imipenem/Cilastatin In Vivo Depicted by Monochromatic Synchrotron X-Ray Microangiography","authors":"Hiroki Nakamura MD,&nbsp;Akira Yamamoto MD, PhD,&nbsp;Hiroyuki Watanabe MD,&nbsp;Minoru Hayashida MD, PhD,&nbsp;Atushi Higaki MD, PhD,&nbsp;Akihiko Kanki MD, PhD,&nbsp;Takeshi Fukunaga MD, PhD,&nbsp;Takuma Maruhisa MD,&nbsp;Yoshihiko Fukukura MD, PhD,&nbsp;Tsutomu Tamada MD, PhD","doi":"10.1016/j.jvir.2024.10.025","DOIUrl":"10.1016/j.jvir.2024.10.025","url":null,"abstract":"<div><h3>Purpose</h3><div>To elucidate the characteristics of imipenem (IPM)/cilastatin (CS) as an embolic material in microvessels in vivo.</div></div><div><h3>Materials and Methods</h3><div>Three healthy rabbits were injected subcutaneously in 1 auricle with picibanil (OK-432) in advance to create an inflammation-induced neovascular model. Microangiography was performed using monochromatic X-rays obtained from a large synchrotron radiation facility (SuperPhoton ring-8 GeV, SPring-8). All rabbits underwent pre-embolic microangiography under anesthesia. Embolization from the central branch of the auricular artery was then performed using a mixture of IPM/CS (0.2 g) + nonionic contrast medium (2 mL). Microangiography was performed immediately after and at 10, 20, 30, 40, 50, 60, 70, 80, and 90 minutes after embolization. The diameter of embolized vessels was measured from the images immediately after embolization. Recanalization times were evaluated from immediately after embolization to 90 minutes after embolization, and they were compared between normal sites and sites where inflammation was induced.</div></div><div><h3>Results</h3><div>The mean diameter of the embolized vessels immediately after embolization evaluated at the normal site was 267 μm (SD ± 58.35; range, 174–363 μm). Evaluation of postembolic recanalization showed that vessels in the normal sites recanalized after a mean of 70 minutes (range, 50–70 minutes), whereas vessels at the sites of inflammation did not recanalize in observations up to 90 minutes after embolization.</div></div><div><h3>Conclusions</h3><div>Microangiography using monochromatic X-rays produced from large synchrotron radiation showed that vessels larger than the IPM/CS particles were initially occluded, but the embolic effect resolved in normal vessels within 70 minutes and persisted in inflamed vessels. IPM/CS may thus exert a selective embolic effect on inflammation-related neovasculature.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 2","pages":"Pages 340-346"},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142559257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Emergency Plug-Assisted Retrograde Transvenous Obliteration (PARTO) for Active Bleeding from Ruptured Gastric Varices.","authors":"Eunbyeol Ko, Jeongyeon Kim, Dong Il Gwon, Hee Ho Chu, Gun Ha Kim, Gi-Young Ko","doi":"10.1016/j.jvir.2025.01.049","DOIUrl":"https://doi.org/10.1016/j.jvir.2025.01.049","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the safety and efficacy of emergency plug-assisted retrograde transvenous obliteration (PARTO) for active bleeding from ruptured gastric varices (GVs).</p><p><strong>Materials and methods: </strong>Twenty-one patients with active bleeding from ruptured GVs were included in this retrospective study. Ten (47.6%) patients showed life-threatening hemorrhage (systolic blood pressure < 90mmHg) just before emergency PARTO. All patients underwent emergency PARTO after initial insufficient endoscopic cyanoacrylate injection (n=9) or because endoscopic injection was not possible (n=12).</p><p><strong>Results: </strong>Emergency PARTO was technically successful in all 21 patients. The mean fluoroscopic time was 30.8 minutes (range, 10-62 minutes). There were no procedure-related adverse events. Hemostasis was obtained in 20 of 21 (95.2%) patients immediately after PARTO. In 16 patients who underwent CT, complete thrombosis or obliteration of GVs and portosystemic shunt was observed. With the exception of one patient who underwent external transfer, 15 patients died within a mean of 196 days (range, 1-1111 days), while five remained alive for a mean of 38.9 months (range, 17.1-74.2 months). Seven died within 30 days due to ischemia-related multiorgan failure (n=5), hypovolemic shock (n=1), or rapid progression of hepatocellular carcinoma (HCC) (n=1). The causes of death in the remaining nine patients were bleeding from EVs (n=2), liver failure (n=2), and rapid progression of HCC (n=5). The median patient survival time was 47 days (95% confidence interval, 0‒124 days). There was no case of rebleeding or recurrence of GVs.</p><p><strong>Conclusion: </strong>Emergency PARTO appears to be a fast, safe, and effective treatment option for patients with active bleeding from ruptured GVs.</p>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143124010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Successful Staged Closure of a Congenital Portosystemic Shunt Using a Constrained Stent Graft.","authors":"Omar Abu Anza, Mohammad Amarneh, Moeez Hasan, Osamah Aldoss, Bassel Mohammad Nijres","doi":"10.1016/j.jvir.2025.01.046","DOIUrl":"https://doi.org/10.1016/j.jvir.2025.01.046","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":" ","pages":""},"PeriodicalIF":2.6,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143124015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}